On Tuesday a national program to provide free preventative drugs to uninsured Americans at risk of HIV was announced.
The program is called “Ready, Set, PrEP.”
To qualify, participants must test negative for HIV, have a valid prescription for the medication, and not have any prescription drug coverage.
The drugs will be donated by Gilead Sciences, makers of Truvada and Descovy, the only two PrEP medications currently approved by the U.S. Food and Drug Administration.
PrEP is a HIV prevention pill.
The company will donate over two million bottles annually, enough to treat 200-thousand Americans, for next level 11 years.
In President Trump’s February State of the Union speech he set the goal to end the HIV epidemic.
In May, he announced the agreement with Gilead.
The Closed Caption version of this video can be found here: https://sign1news.com/2019/12/04/sign1news-12-4-19/
Sign1News is the first and only digital network, partnered with world news leader CNN, to offer on-line news and information in American Sign Language. Sign1News provides equal access to local, regional and national news and information to the Deaf and hard-of-hearing community via a daily post-produced broadcast. Sign1News: Your Life. Your Language.